|
{"source_url": "https://www.newscientist.com", "url": "https://www.newscientist.com/article/mg24532633-300-the-global-failure-to-push-prep-is-hindering-the-fight-against-hiv/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home", "title": "The global failure to push PrEP is hindering the fight against HIV", "top_image": "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg", "meta_img": "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg", "images": ["https://images.newscientist.com/wp-content/uploads/2015/08/ns-logo-for-featured-image.jpg?width=800", "https://www.newscientist.com/wp-content/themes/new-scientist/assets/img/logo.svg", "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg"], "movies": [], "text": "The UN set a target of 3 million people on the HIV prevention drug PrEP by 2020 \u2013 but lingering prejudice and sheer ignorance of its existence mean we're nowhere near\n\nJosie Ford\n\nIN 2016, the UN issued its \u201cPolitical Declaration on Ending AIDS\u201c, aiming to rid the world of the HIV epidemic by 2030. One target for 2020 was to reduce new HIV infections to fewer than 500,000 by, among other things, reaching 3 million at-risk people with pre-exposure prophylaxis (PrEP) by this year. But this target is set to be missed by a country mile, hindering the global fight.\n\nPrEP is a pill containing two chemicals, tenofovir and emtricitabine, that kills HIV before it can infect a person. It can be taken either daily, or at specific \u2026", "keywords": [], "meta_keywords": ["hib", "prep", "aids", "hiv prevention", "medical drugs", "UN", "unaids"], "tags": [], "authors": [], "publish_date": null, "summary": "", "article_html": "", "meta_description": "The UN set a target of 3 million people on the HIV prevention drug PrEP by 2020 \u2013 but lingering prejudice and sheer ignorance of its existence mean we're nowhere near", "meta_lang": "en", "meta_favicon": "/wp-content/themes/new-scientist/img/layup/new-sci-favicon.ico", "meta_data": {"viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.5", "thumbnail": "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg", "p": {"domain_verify": "c64e8f4ac4f50bca3404abba4882a79d"}, "og": {"locale": "en_US", "type": "article", "title": "The global failure to push PrEP is hindering the fight against HIV", "url": "https://www.newscientist.com/article/mg24532633-300-the-global-failure-to-push-prep-is-hindering-the-fight-against-hiv/", "site_name": "New Scientist", "description": "The UN set a target of 3 million people on the HIV prevention drug PrEP by 2020 \u2013 but lingering prejudice and sheer ignorance of its existence mean we're nowhere near", "image": "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg"}, "twitter": {"card": "summary", "creator": "@newscientist", "site": "@newscientist", "image": "https://images.newscientist.com/wp-content/uploads/2020/01/23134306/prep_jan04.jpg", "description": "The UN set a target of 3 million people on the HIV prevention drug PrEP by 2020 \u2013 but lingering prejudice and sheer ignorance of its existence mean we're nowhere near", "title": "The global failure to push PrEP is hindering the fight against HIV | New Scientist"}, "news_keywords": "hib,prep,aids,hiv prevention,medical drugs,un,unaids", "description": "The UN set a target of 3 million people on the HIV prevention drug PrEP by 2020 \u2013 but lingering prejudice and sheer ignorance of its existence mean we're nowhere near", "keywords": "hib, prep, aids, hiv prevention, medical drugs, UN, unaids", "ob_page_type": "paywall", "onesignal": "wordpress-plugin"}, "canonical_link": "https://www.newscientist.com/article/mg24532633-300-the-global-failure-to-push-prep-is-hindering-the-fight-against-hiv/"} |
